24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

Hilkka Soininen(University of Eastern Finland), Noel Ellison, Ineke van Rossum, Tarja Lappalainen, Maxine Luley, Niklas Koehler, Yawu Liu(University of Eastern Finland), Tobias Hartmann(RWTH Aachen University), Suzanne Hendrix(TetraLogic Pharmaceuticals (United States)), Christian Mychajliw, Stephan Schiekofer, Kaj Blennow(Sahlgrenska University Hospital), Philip Scheltens(Inserm), Daniela Ramelli, Miia Kivipelto(University of Eastern Finland), Pieter Jelle Visser(Karolinska Institutet), Lars‐Olof Wahlund(Karolinska Institutet), Göran Hagman, J.M.L. Henselmans, Lucrezia Hausner(Heidelberg University), Stina Lindblom, Aline Klees-Rollmann, Anneke M.J. van Hees, Gerwin Roks(St. Elisabeth Hospital), Frederik Barkhof(Netherlands Institute for Neuroscience), Marcus O.W. Grimm, Ilona Hallikainen, Dieter Lütjohann(University of Bonn), Robert Schomburg, Mara ten Kate(Christian-Albrechts-Universität zu Kiel), Daniela Bertens, Epameinondas Lyros, Teemu Paajanen(Finnish Institute for Health and Welfare), Alina Solomon(University of Eastern Finland), Yvonne Freund‐Levi(Karolinska Institutet), Klaus Faßbender(Saarland University), Jennifer Kennel, Niels Andreasen, Thomas Leyhe(University of Tübingen), Merja Hallikainen, Lutz Frölich(Heidelberg University), Hans H. Klünemann, Johannes Schröder, Nienke M.E. Scheltens(Amsterdam UMC Location Vrije Universiteit Amsterdam), Christoph Laske(University Children's Hospital Tübingen), Seppo Helisalmi(University of Eastern Finland)
The Lancet Neurology
October 30, 2017
Cited by 244


Related Papers